oncology reports Archives

Cannabinoids may provide a treatment option for prostate cancer that has become nonresponsive to common therapy, according to a study published in the February issue of the journal Oncology Reports, and published online this week by the National Institute of Health.

According to researchers; “In the early stages, prostate cancer is androgen‑ dependent; therefore, medical castration has shown significant results during the initial stages of this pathology. Despite this early effect, advanced prostate cancer is resilient to such treatment.”